![Umweltschützer Motte Kranke Person only one occurrence results cannot be generalized academic writing Stahl instabil Vase Umweltschützer Motte Kranke Person only one occurrence results cannot be generalized academic writing Stahl instabil Vase](https://i1.rgstatic.net/publication/332143597_Second_Language_Academic_Writing_A_Study_of_Teachers'_Beliefs_and_Pedagogical_Practices_in_Senior_High_School/links/5e66364f92851c7ce0536b5b/largepreview.png)
Umweltschützer Motte Kranke Person only one occurrence results cannot be generalized academic writing Stahl instabil Vase
Incidence, co-occurrence, and evolution of long-COVID features: A 6-month retrospective cohort study of 273,618 survivors of COVID-19
![Frontiers | EEG Characteristics and Diagnostic Implications in Childhood Headache: A Multi-Center Study | Neurology Frontiers | EEG Characteristics and Diagnostic Implications in Childhood Headache: A Multi-Center Study | Neurology](https://www.frontiersin.org/files/Articles/569486/fneur-11-569486-HTML/image_m/fneur-11-569486-g001.jpg)
Frontiers | EEG Characteristics and Diagnostic Implications in Childhood Headache: A Multi-Center Study | Neurology
![Umweltschützer Motte Kranke Person only one occurrence results cannot be generalized academic writing Stahl instabil Vase Umweltschützer Motte Kranke Person only one occurrence results cannot be generalized academic writing Stahl instabil Vase](https://i1.rgstatic.net/publication/313868072_Collocations_in_Corpus-Based_Language_Learning_Research_Identifying_Comparing_and_Interpreting_the_Evidence_Collocations_in_Corpus-Based_Language_Learning_Research/links/59b1acbc458515a5b4893dd5/largepreview.png)
Umweltschützer Motte Kranke Person only one occurrence results cannot be generalized academic writing Stahl instabil Vase
![Co‐occurrence is not evidence of ecological interactions - Blanchet - 2020 - Ecology Letters - Wiley Online Library Co‐occurrence is not evidence of ecological interactions - Blanchet - 2020 - Ecology Letters - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/0198d263-2c52-45c9-b703-255f276ae3ab/ele13525-fig-0003-m.jpg)
Co‐occurrence is not evidence of ecological interactions - Blanchet - 2020 - Ecology Letters - Wiley Online Library
![The SANAD II study of the effectiveness and cost-effectiveness of valproate versus levetiracetam for newly diagnosed generalised and unclassifiable epilepsy: an open-label, non-inferiority, multicentre, phase 4, randomised controlled trial - The Lancet The SANAD II study of the effectiveness and cost-effectiveness of valproate versus levetiracetam for newly diagnosed generalised and unclassifiable epilepsy: an open-label, non-inferiority, multicentre, phase 4, randomised controlled trial - The Lancet](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/b95c4be7-445d-43cc-b168-277d65e0b030/gr2_lrg.jpg)
The SANAD II study of the effectiveness and cost-effectiveness of valproate versus levetiracetam for newly diagnosed generalised and unclassifiable epilepsy: an open-label, non-inferiority, multicentre, phase 4, randomised controlled trial - The Lancet
![The Complexity Approach to Phonological Treatment: How to Select Treatment Targets | Language, Speech, and Hearing Services in Schools The Complexity Approach to Phonological Treatment: How to Select Treatment Targets | Language, Speech, and Hearing Services in Schools](https://pubs.asha.org/cms/asset/ca877072-62d4-49d4-bcc7-b53feb641150/lshss-17-0082storkel_featimage.jpg)
The Complexity Approach to Phonological Treatment: How to Select Treatment Targets | Language, Speech, and Hearing Services in Schools
![The SANAD II study of the effectiveness and cost-effectiveness of valproate versus levetiracetam for newly diagnosed generalised and unclassifiable epilepsy: an open-label, non-inferiority, multicentre, phase 4, randomised controlled trial - The Lancet The SANAD II study of the effectiveness and cost-effectiveness of valproate versus levetiracetam for newly diagnosed generalised and unclassifiable epilepsy: an open-label, non-inferiority, multicentre, phase 4, randomised controlled trial - The Lancet](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/27f8fcbd-881a-427e-ac6b-8f4399db782d/gr3_lrg.jpg)